Magellan Health, Inc. (MGLN) — Financial statements
Income statement, balance sheet, and cash flow for Magellan Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4,578↓36.1% | 7,159↓2.1% | 7,314↑25.3% | 5,839↑20.7% | 4,837 | |
| Cost of Revenue | 4,459↓35.7% | 6,930↓2.6% | 7,117↑27.8% | 5,568↑21.6% | 4,578 | |
| Gross Profit | 119↓48.2% | 229↑16.3% | 197↓27.2% | 271↑4.7% | 259 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 877 | |
| Other Expenses | 98↓25.2% | 132↓0.9% | 133↑14.7% | 116↑115.0% | -771 | |
| Operating Expenses | 98↓25.2% | 132↓0.9% | 133↑14.7% | 116↑9.1% | 106 | |
| Total Costs & Expenses | 4,557↓35.5% | 7,062↓2.6% | 7,250↑27.6% | 5,683↑21.3% | 4,684 | |
| Operating Results | ||||||
| Operating Income | 369↑215.2% | 117↑48.8% | 79↓51.3% | 161↑2.2% | 158 | |
| Depreciation & Amortization | 119↓9.7% | 132↓0.9% | 133↑14.7% | 116↑9.1% | 106 | |
| EBITDA | 109↓56.1% | 248↑17.6% | 211↓23.7% | 277↑5.0% | 264 | |
| EBIT | -10↓108.2% | 117↑48.8% | 79↓51.2% | 161↑3.5% | 156 | |
| Interest & Other Income | ||||||
| Net Interest Income | -27↓58.0% | -17↑20.5% | -21↓6.2% | -20↓172.4% | -7 | |
| Interest Income | 4↓78.9% | 19↑36.4% | 14↑139.0% | 6↑108.9% | 3 | |
| Interest Expense | 31↓14.6% | 36↑2.1% | 35↑36.3% | 26↑154.9% | 10 | |
| Non-Operating Income | 378 | 0.00 | 0.00↓100.0% | 0.07↓96.8% | 2 | |
| Other Income / Expenses | -409↓1031.7% | -36↓2.1% | -35↓35.9% | -26↓112.0% | -12 | |
| Income Before Tax | -40↓150.1% | 81↑87.1% | 43↓68.1% | 135↓7.1% | 146 | |
| Income Tax Expense | -45↓278.7% | 25↑31.0% | 19↓24.2% | 25↓64.0% | 70 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 4↓92.8% | 56↑131.2% | 24↓78.0% | 110↑45.3% | 76 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 4↓92.8% | 56↑131.2% | 24↓78.0% | 110↑45.3% | 76 | |
| Bottom-Line Net Income | 4↓92.8% | 56↑131.2% | 24↓78.0% | 110↑45.3% | 76 | |
| EPS (Basic) | 0.16↓93.0% | 2.28↑135.1% | 0.97↓79.4% | 4.72↑44.3% | 3.27 | |
| EPS (Diluted) | 0.16↓93.0% | 2.28↑135.1% | 0.97↓78.5% | 4.51↑43.6% | 3.14 | |
| Weighted Average Shares | 26↑5.0% | 25↓1.9% | 25↑7.3% | 23↑0.7% | 23 | |
| Weighted Average Diluted Shares | 26↑5.0% | 25↓1.9% | 25↑2.4% | 24↑1.2% | 24 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.